Muscle loss risk at significant caloric deficits, muscle loss becomes a real concern
Cycling between protocols: Some patients alternate using CJC/Ipa during active training blocks and sermorelin during recovery or lower-intensity phases
Interestingly, this initial weight loss is no different from other weight loss treatments, nor is it the impact of diet interventions on weight loss
Semaglutide helps break this cycle
Studies have directly compared the effects of the two treatments on the risk of MASLD/MASH, with results showing that both can improve hepatic steatosis and liver enzymes, though the differences may not be statistically significant
Beyond this well-recognized pattern, observational reports describe other eye findings in smaller numbers of patients, though direct cause-and-effect relationships remain uncertain